Key protective strategies include: Pre-treatment ophthalmologic evaluation : Establish baseline retinal status before initiating GLP-1 therapy, particularly in patients with diabetes duration exceeding 10 years or poor prior glycemic control Individualized medication titration : Consider a more gradual dose escalation approach to avoid precipitous drops in blood glucose for patients with advanced diabetic retinopathy, in coordination with ophthalmology care Appropriate monitoring : Discuss with your healthcare provider whether more frequent eye examinations are needed based on your individual risk factors and baseline retinal status Prompt reporting of visual symptoms : Contact your healthcare provider immediately if you experience sudden vision loss, new or dense floaters, flashing lights, a "curtain" over your vision, eye pain with vision changes, or any sudden vision disturbance Patients without pre-existing diabetic retinopathy can generally follow standard eye examination schedules and do not require additional ophthalmologic monitoring solely due to GLP-1 use
NAC may be more readily absorbed and utilized than supplemental glutathione itself, while liposomal delivery enhances direct glutathione absorption
Take Action Seek expert care at MINT STL If youre experiencing symptoms of neuropathy, MINT STL is here to provide comprehensive, personalized treatment tailored to your needs
Similar content being viewed by others Background Hepatitis C virus (HCV) is classified into seven genotypes, 67 confirmed subtypes and 20 provisionally assigned subtypes [1, 2]
